A study in people with type 2 diabetes.

Recruiting now. Registry record last updated June 11, 2026.

Who can join: Adults 18 to 60, have obesity or are overweight.
What you take: Check ClinicalTrials.gov for this trial's study groups and what each group receives.
How long it lasts: The study runs about 8 months.
What you get: Costs vary by study. Ask the study team what this one covers, including the study medicine, visits and travel, before you sign the consent form.

This one may not fit you. We check your age, where you live, and the rules each study sets, then show the clinical trials that do.

Check my fit →

Phase Not ApplicableSponsor State University of New York at BuffaloDrug investigational drugClass OtherSites 1 USEnrollment target 30

What this study is for

Primary condition: Obesity & Overweight. Also studied in: Type 2 Diabetes, Type 2 Diabetes (Adult Onset), Obesity Type 2 Diabetes Mellitus, Dehydration.

Full scientific study title: Hydration Intervention to Decrease Side Effects Associated With GLP - 1 RA Therapy.

Who can join

Age18 to 60SexAny

Adults 18 to 60, have obesity or are overweight. A site coordinator confirms whether you qualify during a free screening visit. The exact medical requirements are below.

Full medical eligibility (for you and your doctor)verbatim from the registry

This is the exact wording from ClinicalTrials.gov, including clinical measures (lab values, imaging scores). Bring it to your doctor if any of it is unclear.

Key inclusion criteria

Adults aged 18-60
Recently prescribed a GLP-1RA (within one week of prescription)
Fluent in English
Willing to complete the study protocol

Key exclusion criteria

Children and adults \> 60 years of age
Those not taking a GLP-1RA
Those who have been on a GLP-1RA longer than one week
Not fluent in English
Those who are pregnant or planning on becoming pregnant during the duration of the study

Where this trial is enrolling

This trial has 1 sites across 1 state. Contact a site coordinator directly to start screening.

New York1 site

State University of New York at Buffalo, South Campus
Buffalo, New York
Hannah E Kolpack, BS(716) 829 - 5820hkolpack@buffalo.edu

Follow this trial

We email you if NCT07641361 changes status, adds new sites in your state, or if a similar trial opens for the same condition.

Timeline

Started enrolling: June 15, 2026. Expected completion: February 1, 2027. Last updated on ClinicalTrials.gov: June 11, 2026.

Official source

Every Monday we check this trial against ClinicalTrials.gov, the federal registry for clinical research. Last checked September 4, 2026. Confirm the current status there before you contact a site:

View on ClinicalTrials.gov →

Back to the full directory → or take the matching quiz if you want clinical trials filtered to your conditions and location.

John Samaras, Founder and EditorI started GLP Chart after overpaying for a GLP-1 myself. Based in Austin, Texas.
About this site LinkedIn Contact

Why you can trust GLP Chart. Same scoring framework applied to every program. No paid placements. We never remove unfavorable information at an advertiser's request. Pricing is pulled from each program's public-facing page every Monday.